Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Cirrhosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 9 articles: HTML format

Single Articles

August 2025
1. LOOMBA R, Morgan E, Yousefi K, Li D, et al
   Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
   Lancet. 2025;406:821-831.
   PubMed     Abstract available
   
   
   
2. NOUREDDIN M, Frias JP, Neff GW, Lucas KJ, et al
   Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
   Lancet. 2025;406:719-730.
   PubMed     Abstract available
   
   
   May 2025
3. COOKE GS, Hung LM, Flower B, McCabe L, et al
   Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial.
   Lancet. 2025 May 7:S0140-6736(25)00097-2. doi: 10.1016/S0140-6736(25)00097.
   PubMed     Abstract available
   
   
   November 2024
4. ISRAELSEN M, Francque S, Tsochatzis EA, Krag A, et al
   Steatotic liver disease.
   Lancet. 2024;404:1761-1778.
   PubMed     Abstract available
   
   
   September 2024
5. TANAKA A, Ma X, Takahashi A, Vierling JM, et al
   Primary biliary cholangitis.
   Lancet. 2024;404:1053-1066.
   PubMed     Abstract available
   
   
   September 2023
6. TAPPER EB, Serper M
   Screening for advanced liver disease in the general population.
   Lancet. 2023;402:941-943.
   PubMed    
   
   
   
7. SERRA-BURRIEL M, Juanola A, Serra-Burriel F, Thiele M, et al
   Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
   Lancet. 2023;402:988-996.
   PubMed     Abstract available
   
   
   May 2023
8. ADAMS PC, Jeffrey G, Ryan J
   Haemochromatosis.
   Lancet. 2023;401:1811-1821.
   PubMed     Abstract available
   
   
   February 2023
9. JENG WJ, Papatheodoridis GV, Lok ASF
   Hepatitis B.
   Lancet. 2023 Feb 9:S0140-6736(22)01468-4. doi: 10.1016/S0140-6736(22)01468.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.